To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks
Clinical trial NCT05606107 · UNKNOWN
Trial details
- NCT number
- NCT05606107
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2024-06-30
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.